Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Rogier M. Reijmers et al.|Journal of Clinical Investigation|2019Cited by 232
Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8Jordi Berenguer, Thomas Würdinger, Laurine E. Wedekind et al.|Journal of Extracellular Vesicles|2018Cited by 104
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple MyelomaAnna Luise Grab, Marc S. Raab, Peter Kim et al.|Cells|2024Cited by 18
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I. van der Lee, Marieke Griffioen, Georgia Koutsoumpli et al.|Cancers|2021Cited by 14
Abstract A044: Mutated NPM1 as target for immunotherapy of acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Rogier M. Reijmers et al.|Cancer Immunology Research|2019Cited by 0